Stay updated on Dolutegravir Plus NRTIs in HIV-2 Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.

Latest updates to the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page
- Check4 days agoChange DetectedPage revision updated from v3.6.6 to v3.7.0, representing a version update of the page. This change does not alter the study details or content presented on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe Revision label in the page footer was updated from v3.6.5 to v3.6.6, indicating a new version of the ClinicalTrials.gov page.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page's revision label has been updated from v3.6.4 to v3.6.5, signaling a minor update to the page template or content without changing the study data.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.6.4 was added and Revision: v3.6.3 removed, updating the page’s revision label to reflect a new version. This change is a metadata update rather than a modification to the study content or data.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.3, signaling a newer version of the study record.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page now includes new guidance and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays a recruitment status update ('No longer looking for participants'). The Intervention/Treatment header formatting was updated, and the revision label changed from v3.5.5 to v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Dolutegravir Plus NRTIs in HIV-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Plus NRTIs in HIV-2 Clinical Trial page.